T
Tekla Life Sciences Investors
Q1 2025 earnings expected
Quarter
Jan – Mar
Expected
May 15, 2025(ET)
Revenue
This quarter$18M
Year ago (Mar '24)$2M▲ +781.2%
EPS
Turned to a loss
This quarter-$1.64
Year ago (Mar '24)$1.84
Revenue Growth Trajectory
+164%YoY
Last 7 quarters